St. Jude Medical is a global medical device company.
The company was founded by Manny Villafana in 1976 as a developer of artificial heart valves.
In 1986 St. Jude Medical expanded into tissue heart valves when it acquired BioImplant.
In 1990 the company expanded internationally for the first time when it opened an office in Belgium.
Today St. Jude Medical operates in two business segments: Implantable Electronic Systems and Cardiovascular and Ablation Technologies.
Implantable Electronic Systems includes pacemakers and implantable cardiac defibrillators.
The company sells its products in more than 100 countries, though the U.S. is its biggest market.
St. Jude Medical trades publicly on the New York Stock Exchange under the ticker symbol STJ, is a member of the S&P 500, is #462 in the Fortune 500, has 16,000 employees, and had $5.57 billion in revenue in 2013.
St. Jude Medical is a global medical device company.
The company was founded by Manny Villafana in 1976 as a developer of artificial heart valves.
In 1986 St. Jude Medical expanded into tissue heart valves when it acquired BioImplant.
History
In 1990 the company expanded internationally for the first time when it opened an office in Belgium.
Today St. Jude Medical operates in two business segments: Implantable Electronic Systems and Cardiovascular and Ablation Technologies.
Implantable Electronic Systems includes pacemakers and implantable cardiac defibrillators.
The company sells its products in more than 100 countries, though the U.S. is its biggest market.
St. Jude Medical trades publicly on the New York Stock Exchange under the ticker symbol STJ, is a member of the S&P 500, is #462 in the Fortune 500, has 16,000 employees, and had $5.57 billion in revenue in 2013.